MAB-Solut

MAB-Solut is a biotechnology company and contract research organization specializing in the discovery and optimization of therapeutic antibodies. The company utilizes a proprietary mammalian cell surface display platform to identify high-affinity monoclonal antibodies directly in their final IgG format, bypassing the need for conversion from other systems like phage display. Their services include antibody humanization, affinity maturation, and the development of complex formats such as bispecific antibodies and antibody-drug conjugates (ADCs). By integrating advanced flow cytometry and bioinformatics, MAB-Solut aims to accelerate the development of biologics for pharmaceutical partners.